Abstract:Dialysis-related amyloidosis derived from the precursor protein /?2-microglobulin, is a frequent cause of mor- bidity and a potential cause of mortality in patients on long-term renal replacement therapy. Dialysis-related amyloidosis can be prevented by early restitution of renal function following a successful renal transplanta- tion. However, once established, no definitive therapy exists and at best further progression can be prevented (1). If no definitive cure exists, why then perform expensive and sometimes invasive diagnostic tests to confirm the clinical suspicion of amyloid deposition? There are various reasons: first and most important, to exclude potentially treatable diseases; second, to prescribe adequate palliative therapy and to focus attention on sites that may require palliative therapy in the future (e.g. cystic bone radiolucencies prone to pathological fractures); and third, to obtain more insight into the natural course and pathogenesis of dialysis-related amyloidosis. As discussed elsewhere, current clinical tools for the diagnosis of amyloidosis suffer either from their lack of specificity or, in the case of biopsies, from their high degree of invasiveness and the limited amount of information obtained (2). As far as scintigraphy is concerned, traditional 'amyloid-scans', employing "raTc-tagged phosphates, (67Ga)-citrate or (" mTc(V)) DMSA, are non-specific and have not been useful for the diagnosis of dialysis- related amyloidosis (reviewed in 2). Recently, however, scanning using either its radiolabelled precursor pro- tein, /?2-microglobulin (3), or a minor constituent bound to all types of amyloid fibrils, the amyloid P component (4), have been introduced as non-invasive diagnostic tools. Scintigraphy with (131I)/?2-micro- globulin was shown to be more sensitive than the combination of clinical and X-ray findings, to be specific for dialysis-related amyloidosis, and to be reproducible (3). Scintigraphy with 123I-labelled serum amyloid P component in dialysis patients has resulted in findings that in some aspects contradict those obtained with (131I)/?2-microglobulin. Using the serum amyloid P scan the spleen was frequently positive in haemodialysis patients while tracer accumulation was only rarely observed in deep joints such as the hip (4). Current knowledge based on histological findings, how- ever, suggests that the spleen is not a predilection site for dialysis-related amyloidosis, while involvement of large joints such as the hip is common (2). Consequently, definitive data on the sensitivity and specificity of the amyloid P component scan remain to be established. Current disadvantages of both the /?2- microglobulin and the amyloid P component scan are that they use proteins isolated from human blood, that they are not yet licenced for general use, and that in the case of /? 2-microglobulin scanning the amount of radioactivity administered is comparatively high. Thus, in order to make the scans more widely available, current research is directed towards replacing the nat- ural proteins with recombinant ones or fragments thereof and improving the radiolabelling. Can scanning with (131I)/J2-microglobulin reveal insights into the pathogenesis of dialysis-rela ted amyl- oidosis? Possibly. First of all, experiments confirm that dialysis-related amyloidosis is indeed derived, at least in part, from circulating and not from locally produced /?2-microglobulin. Secondly, it was observed that there is a 48-h lag phase between injection of the tracer and the first visualization of deposits (3). This could indicate that in the pathogenesis of dialysis-related amyloidosis, as in that of other amyloid types, a processing step is required before the precursor protein is incorporated into the fibrils. This hypothesis is consistent with the finding of proteolytical ly modified /?2-microglobulin molecules in dialysis-rela ted amyloidosis fibrils (5). Thirdly, deposits have also been detected by ( 131I)/?2- microglobulin scanning in patients treated exclusively with CAPD (2), which is in agreement with clinical data showing that its pathogenesis does not depend on blood-dialyser interactions (6). Finally, scanning of a large number of haemodialysis patients has confirmed the clinical impression (7) that one factor favouring deposition early during the course of haemodialysis is old age (8). Wider application of /?2-microglobulin scanning, and in particular the thorough analysis of those rare patients who are still scan-negative after more than 15 years of haemodialysis , may reveal additional clues to the pathogenesis of dialysis-rela ted amyloidosis. Furthermore, scanning with /^-micro- globulin may at last provide an objective and sensitive

Symmetric Diffeomorphic Image Registration with Multi-Label Segmentation Masks

One registration is worth two segmentations

Deep learning based brain MRI registration driven by local-signed-distance fields of segmentation maps.

Multimodal Medical Image Registration Via Common Representations Learning and Differentiable Geometric Constraints

Deformable Registration of Ultrasound and Magnetic Resonance Imaging Using A New Self-Similarity Based Neighborhood Descriptor

Image Segmentation with Adaptive Spatial Priors from Joint Registration

Multi-source Remote Sensing Image Registration Based on Sift and Optimization of Local Self-Similarity Mutual Information

Symmetric-Constrained Irregular Structure Inpainting for Brain MRI Registration with Tumor Pathology

A Novel Unsupervised Learning Model for Diffeomorphic Image Registration

Joint segmentation and discontinuity-preserving deformable registration: Application to cardiac cine-MR images

A Symmetric Dynamic Learning Framework for Diffeomorphic Medical Image Registration

Anatomically Constrained and Attention-Guided Deep Feature Fusion for Joint Segmentation and Deformable Medical Image Registration.

The Method of Multimodal MRI Brain Image Segmentation Based on Differential Geometric Features

Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain

Multiscale feature fusion network for 3D head MRI image registration

Digital Analysis of Smart Registration Methods for Magnetic Resonance Images in Public Healthcare

Registration of Multi-Modal Images under a Complex Background Combining Multiscale Features Extraction and Semantic Segmentation.

Feature-based groupwise registration by hierarchical anatomical correspondence detection

Beta 2-microglobulin-derived amyloidosis: clinical use of scintigraphy and insights into its pathogenesis.

A Nonrigid Registration Framework Using Spatially Encoded Mutual Information and Free-Form Deformations

A coarse-to-fine framework for unsupervised multi-contrast MR image deformable registration with dual consistency constraint